Close

Articles Posted in Defective Drugs

Updated:

Class I Recall for Disposable Syringes

Excelsior Disposable 5mL fill in 6mL prefilled saline flush syringes are supposed to be used for the flushing of venous access devices, such as inserted central catheters and intravenous (IV) lines. However, a batch of these syringes that were distributed in August 2010 has now been determined to create risks…

Updated:

MRI Gadolinium-based Contrast Dye Label Change Due to Life Threatening Risk

Nearly two years ago, the FDA received a high number of adverse events reports relating to Gadolinium-based (GADO) Contrast Dyes used in MRI testing. Adverse events reports are used to describe incidents in which a user of a drug is injured because of the ingredients in the product. In the…

Updated:

Indiana Meth Laws: Time for Improvements

In Indiana, laws already restrict the sale of methamphetamine and related over-the-counter drugs such as select cold medicines which contain meth. Today, Indiana lawmakers are taking meth restrictions to the next level with the introduction of a proposal that would not allow pharmacies to sell pseudoephedrine without a prescription from…

Updated:

Dietary Supplements Recalls, Totaling 62 Products

Sixty two dietary supplement products have been removed from the nationwide and international market following an investigation uncovering that the supplements contain steroid or steroid-like substances that were not approved by the FDA. The recalling firm is Bodybuilding.Com, Meridian, ID. The recall began in November 2009 and is still ongoing,…

Updated:

Reglan and Tardive Dyskinesia

Reglan, manufactured by Baxter Healthcare Corporation, has long been used in over 2 million children and adults for the treatment of gastrointestinal conditions such as diabetic gastroparesis disease and gastroesophageal reflux disease. The ill effects of Reglan use has not become fully apparent until recently. The FDA has announced that…

Updated:

Know What to Consider in the Yaz Recall Bayer Lawsuits

In November of 2009, Yaz and a similar product Ocella were recalled following reports of serious injury in users as young as thirteen years old. The problems associated with Yaz and Ocella involve the dosage of drospirenone which is known for creating health problems in users that live in European…

Contact Us